ProMIS Neurosciences, Inc. (PMN)
12.30
+0.25
(+2.07%)
USD |
NASDAQ |
Apr 15, 16:00
12.20
-0.10
(-0.81%)
Pre-Market: 20:00
ProMIS Neurosciences Total Liabilities (Quarterly) : 10.44M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Oncolytics Biotech, Inc. | 11.38M |
| Aurinia Pharmaceuticals, Inc. | 189.26M |
| Edesa Biotech, Inc. | 0.7562M |
| Lexaria Bioscience Corp. | 0.277M |
| Xenon Pharmaceuticals, Inc. | 399.91M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 9.182M |
| Shareholders Equity (Quarterly) | -1.259M |
| Current Ratio | 0.8788 |